StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) stock

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)

Close on Nov 18, 2026Market cap $13.37MP/E –Yield –

Matinas BioPharma gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Matinas BioPharma

Matinas BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Matinas BioPharma figures

See a number that looks wrong?